SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001047469-09-002124
Filing Date
2009-03-02
Accepted
2009-03-02 16:30:05
Documents
12
Period of Report
2008-12-31

Document Format Files

Seq Description Document Type Size
1 10-K a2191115z10-k.htm 10-K 1395072
2 EXHIBIT 10.53 a2191115zex-10_53.htm EX-10.53 20751
3 EXHIBIT 23.1 a2191115zex-23_1.htm EX-23.1 3415
4 EXHIBIT 31.1 a2191115zex-31_1.htm EX-31.1 8347
5 EXHIBIT 31.2 a2191115zex-31_2.htm EX-31.2 8248
6 EXHIBIT 32.1 a2191115zex-32_1.htm EX-32.1 5570
7 G15332KII001.JPG g15332kii001.jpg GRAPHIC 2981
8 G679784.JPG g679784.jpg GRAPHIC 48576
9 G624679.JPG g624679.jpg GRAPHIC 144147
10 G241460.JPG g241460.jpg GRAPHIC 57186
11 G627244.JPG g627244.jpg GRAPHIC 57076
12 G707354.JPG g707354.jpg GRAPHIC 40949
  Complete submission text file 0001047469-09-002124.txt   1927022
Mailing Address
Business Address 15 SKYLINE DRIVE HAWTHORNE NY 10532 914-347-4300
ACORDA THERAPEUTICS INC (Filer) CIK: 0001008848 (see all company filings)

IRS No.: 000000000 | Fiscal Year End: 1231
Type: 10-K | Act: 34 | File No.: 000-50513 | Film No.: 09647801
SIC: 2836 Biological Products, (No Diagnostic Substances)